123I-Ioflupane dopamine transporter imaging (DaTSCAN) appearances in relation to emotional responsiveness, impulsivity and olfaction in suspected Parkinsonian syndrome

Objective The aim of our study was to ascertain relationships between DaTSCAN, olfactory loss, behavioural and subjective measurements of impulsivity and emotional responsiveness in patients with clinically suspected Parkinsonian syndrome (PS). Methods A prospective study of 20 drug-naive patients with parkinsonism, underwent the University of Pennsylvania Smell Identification Test, impulsivity measurements and mood-state-questionnaires before visual and semi-quantitative DaTQUANT analyses. There were two subgroups: nine patients with scans without evidence of dopaminergic deficit (SWEDD – controls) and 11 patients with PS. Results The PS group reported lower non-planning impulsivity than the SWEDD group (P = 0.039). A positive correlation was found between the non-planning impulsivity ratings and right anterior putamen/background (bck) ratio in PS group (r = 0.598, P = 0.068). Higher ratings of anger (r = 0.575, P = 0.016), fatigue (r = 0.746, P = 0.001), confusion (r = 0.561, P = 0.019) and depression were positively correlated with putamen/caudate ratios (R > L) on DaTSCAN. Higher self-reported arousal was associated with lower right putamen/caudate ratio (P = −0.581, P = 0.014). Only fatigue was positively correlated with putamen/bck (r = 0.564, P = 0.018). The degree of smell deficit correlated negatively with performance on reflection impulsivity tasks (r = −0.470, P = 0.049). Conclusion DaTSCAN appearances correlated with emotional dysfunction and self-reported impulsivity in patients with PS. Olfactory impairment was associated with increased reflection impulsivity and the age of patients. Higher DaTSCAN putamen/caudate ratios were associated with higher emotional responsiveness and higher non-planning impulsivity in PS patients. These preliminary findings may be relevant in clinical practice in differentiating PS from SWEDD and identifying susceptibility to impulse control disorder although larger studies are warranted.

[1]  M. Pompili,et al.  Neuropsychiatric disturbances in atypical parkinsonian disorders , 2018, Neuropsychiatric disease and treatment.

[2]  H. Critchley,et al.  The role of emotions and physiological arousal in modulating impulsive behaviour , 2018, Biological Psychology.

[3]  Y. Bordelon,et al.  Parkinsonism , 2016, Seminars in Neurology.

[4]  C. Caltagirone,et al.  Alexithymia in Parkinson's disease: A systematic review of the literature. , 2016, Parkinsonism & related disorders.

[5]  A. Bentivoglio,et al.  Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? , 2015, Journal of the Neurological Sciences.

[6]  K. Chaudhuri,et al.  The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review , 2015, npj Parkinson's Disease.

[7]  L. Lopiano,et al.  Emotion Processing in Parkinson’s Disease: A Three-Level Study on Recognition, Representation, and Regulation , 2015, PloS one.

[8]  R. Bond,et al.  Further evidence of the heterogeneous nature of impulsivity☆ , 2015, Personality and individual differences.

[9]  K. Kralik,et al.  Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson’s disease and essential tremor , 2015, Neurological Sciences.

[10]  M. Potenza,et al.  Importance of Sex Differences in Impulse Control and Addictions , 2015, Front. Psychiatry.

[11]  A. Grace,et al.  Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[12]  Jessica Weafer,et al.  Sex differences in impulsive action and impulsive choice. , 2014, Addictive behaviors.

[13]  M. Moutoussis,et al.  Reflection impulsivity in binge drinking: behavioural and volumetric correlates , 2014, Addiction biology.

[14]  N. Bakhshani Impulsivity: A Predisposition Toward Risky Behaviors , 2014, International journal of high risk behaviors & addiction.

[15]  G. Deuschl,et al.  Alexithymia—an independent risk factor for impulsive‐compulsive disorders in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[16]  I. Litvan,et al.  Behavioral abnormalities in progressive supranuclear palsy , 2013, Psychiatry Research.

[17]  A. Siderowf,et al.  Screening for impulse control symptoms in patients with de novo Parkinson disease , 2013, Neurology.

[18]  U. Bonuccelli,et al.  Affective symptoms and cognitive functions in Parkinson's disease , 2012, Journal of the Neurological Sciences.

[19]  R. Doty Olfactory dysfunction in Parkinson disease , 2012, Nature Reviews Neurology.

[20]  A. Stefani,et al.  Alexithymia is a non-motor symptom of Parkinson disease. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[21]  Nikolaos Karatzas,et al.  SPECT imaging evaluation in movement disorders: far beyond visual assessment , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  R. Levenson,et al.  Alexithymia in neurodegenerative disease , 2011, Neurocase.

[23]  W. Hall,et al.  Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. , 2011, Addiction.

[24]  J Deeb,et al.  A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease. , 2010, QJM : monthly journal of the Association of Physicians.

[25]  R. Postuma,et al.  Clinical prediction of Parkinson's disease: planning for the age of neuroprotection , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  L. Tremblay,et al.  Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.

[27]  M. Stacy,et al.  Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  H. Berendse,et al.  Prevalence of smell loss in Parkinson's disease--a multicenter study. , 2009, Parkinsonism & related disorders.

[30]  Hugo Carretero-Dios,et al.  Role of the Matching Familiar Figures Test-20 in the Analysis of Theoretical Validity of the Reflection-Impulsivity: A Study with Personality , 2009 .

[31]  David J. Brooks,et al.  Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy , 2007, Neuropsychologia.

[32]  Pablo Mir,et al.  Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs) , 2007, Movement disorders : official journal of the Movement Disorder Society.

[33]  V. Voon,et al.  Medication-related impulse control and repetitive behaviors in Parkinson disease. , 2007, Archives of neurology.

[34]  T. Robbins,et al.  Reflection Impulsivity in Current and Former Substance Users , 2006, Biological Psychiatry.

[35]  P. Moberg,et al.  Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.

[36]  W. Weiner,et al.  Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) , 2006, Neurology.

[37]  T. Robbins,et al.  Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  P. Moberg,et al.  [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease , 2005, Neurology.

[39]  D. Dougherty,et al.  Laboratory behavioral measures of impulsivity , 2005, Behavior research methods.

[40]  H. Przuntek,et al.  Facial expression recognition in people with medicated and unmedicated Parkinson’s disease , 2003, Neuropsychologia.

[41]  G. Taylor Recent Developments in Alexithymia Theory and Research , 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[42]  J. Patton,et al.  Factor structure of the Barratt impulsiveness scale. , 1995, Journal of clinical psychology.

[43]  G. Logan On the ability to inhibit thought and action , 1984 .

[44]  R. Doty,et al.  Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.

[45]  Tommy Cammock,et al.  Development of a More Reliable Version of the Matching Familiar Figures Test. , 1978 .

[46]  M. Murata,et al.  [Scans without Evidence of Dopamine Deficit (SWEDDs)]. , 2016, Brain and nerve = Shinkei kenkyu no shinpo.

[47]  A. Cronin-Golomb,et al.  Alexithymia and Apathy in Parkinson’s Disease: Neurocognitive Correlates , 2013, Behavioural neurology.

[48]  D. Mezzapesa,et al.  Parkinsonian syndromes , 2008, Neurological Sciences.

[49]  祐子 佐久田,et al.  Profile of Mood States(POMS)の検討:多次元覚醒理論の立場から , 1997 .

[50]  A J Lees,et al.  When did Ray Kennedy's Parkinson's disease begin? , 1992, Movement disorders : official journal of the Movement Disorder Society.

[51]  R. Marin,et al.  Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[52]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[53]  Deborah A. Day,et al.  Information processing in the child: Significance of analytic and reflective attitudes. , 1964 .